HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decreased Serum Levels of C-Terminal Agrin in Postmenopausal Women Following Resistance Training.

Abstract
Elevated circulating C-terminal agrin fragment (CAF) is a marker of neuromuscular junction degradation and sarcopenia. This study sought to determine if resistance training (RT) impacted the serum levels of CAF in perimenopausal (PERI-M) and postmenopausal (POST-M) women. A total of 35 women, either PERI-M or POST-M, participated in 10 weeks of RT. Body composition, muscle strength, and serum estradiol and CAF were determined before and after the RT. The data were analyzed with two-way analysis of variance (p ≤ .05). Upper body and lower body strength was significantly increased, by 81% and 73% and 86% and 79% for the PERI-M and POST-M participants, respectively; however, there were no significant changes in body composition. Estradiol was significantly less for the POST-M participants at pretraining compared with the PERI-M participants. CAF moderately increased by 22% for the PERI-M participants in response to RT, whereas it significantly decreased by 49% for the POST-M participants. Ten weeks of RT reduced the circulating CAF in the POST-M women and might play a role in attenuating degenerative neuromuscular junction changes.
AuthorsDarryn S Willoughby, Kaitlan N Beretich, Marcus Chen, LesLee K Funderburk
JournalJournal of aging and physical activity (J Aging Phys Act) Vol. 28 Issue 1 Pg. 73-80 (01 01 2020) ISSN: 1543-267X [Electronic] United States
PMID31629361 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Agrin
Topics
  • Agrin (blood, chemistry)
  • Female
  • Humans
  • Middle Aged
  • Muscle Strength
  • Muscle, Skeletal (physiology)
  • Postmenopause (blood)
  • Resistance Training
  • Sarcopenia (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: